Abstract:Introduction: Arylboronates afford rapid aqueous F-18-labeling via the creation of a highly polar F-18-aryltrifluoroborate anion (F-18-ArBF3-).Hypothesis: Radiosynthesis of an F-18-ArBF3- can be successfully applied to a clinically relevant peptide. To test this hypothesis we labeled dimeric-cylcoRGD, [c(RGDfK)](2)E because a) it is molecularly complex and provides a challenging substrate to test the application of this technique and b) [c(RGDfK)](2)E has already been labeled via several F-18-labeling methods which provide for a preliminary comparison.Goal: To validate this labeling method in the context of a complex and clinically relevant tracer to show tumor-specific uptake ex vivo with representative PET images in vivo.Methods: An arylborimidine was conjugated to [c(RGDfK)](2)E to give the precursor [c(RGDfK)](2)E-ArB(dan) which was aliquoted and stored at-20 degrees C. Aliquots of 10 or 25 nmol containing only micrograms of precursor were labeled using relatively low levels of F-18-activity. Following purification eight mice (pre-blocked/unblocked) with U87M xenograft tumors were injected with [c(RGDfK)(2)E-F-18-ArBF3- (n = 4) for ex vivo tissue dissection. Two sets of mice (pre-blocked/unblocked) were also imaged with PET-CT (n = 2).Results: The [c(RGDfK)](2)E-ArB(dan) is converted within 15 min to [c(RGDfK)](2)E-F-18-ArBF3- in isolated radiochemical yields of similar to 10% (n = 3) at a minimum effective specific activity of 0.3 Ci/mu mol. Biodistribution shows rapid clearance to the bladder via the kidney resulting in high tumor-to-blood and tumor-to-muscle ratios of >9 and >6 respectively while pre-blocking with [c(RGDfK)](2)E showed high tumor specificity. PET imaging showed good contrast between tumor and non-target tissues confirming the biodistribution data.Conclusion: An arylborimidine-RGD peptide is rapidly F-18-labeled in one step in good yield at useful specific activity. Biodistribution studies with blocking controls show tumor specificity which is corroborated by PET images.Advances in Knowledge and Implications for patient Care: Despite many antecedent examples of labeled RGD tracers this work is the first to show direct aqueous labeling of bisRGD with an F-18-ArBF3-. Labeling occurs in near record rapidity (45 min) at useful effective specific activities and competitive yields for high contrast tumor specific images. As bisRGD has been imaged in humans with several prosthetics this work suggests potential clinical applications of tracers appended with an F-18-ArBF3- More generally the ability to label a molecularly complex tracer suggests that this method could be useful to label many other peptides. Furthermore these results portend the development of kits that use only microgram quantities of lyophilized precursor for on demand labeling. The ability to perform one-step aqueous labeling in under an hour to provide tracers with high T:NT ratios has important implications for developing radiotracers for use in fundamental research and in preclinical tracer studies. (C) 2013 Elsevier Inc. All rights reserved.

Efficient Automated Synthesis of 2-(5-[18f]fluoropentyl)-2-methylmalonic Acid ([18F]ML-10) on a Commercial Available [18F]FDG Synthesis Module.

The Automated Synthesis of 18F-Fl-10 Using A Microfluidic Chip-Based Synthesizer

A New Simple Automated Synthesis of 6-F-18-dopa with Fluoride

Automated Synthesis of Hypoxia Imaging Agent [ 18 F]FMISO Based Upon a Modified Explora FDG 4 Module

Methodological Progress of 18F-Fluoro-labeling Employing 18F-FDG As Prosthetic Group

Design and implementation of an automated DT-PhotoFluor radiosynthesis module for 18F-fluorination of aliphatic, branched chain amino acids

One-step Radiosynthesis of 18F-Alf-nota-rgd2 for Tumor Angiogenesis PET Imaging

Automated synthesis of 18F-fluoroacetate by using Explora FDG4 module

Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform

Semi-automated Synthesis of 1-[18F]fluoroethyl-L-tryptophan

"[18F]Trifluoroiodomethane – Enabling Photoredox‐mediated Radical [18F]Trifluoromethylation for Positron Emission Tomography

A New Simple Automated Synthesis of the Beta-Amyloid Imaging Radiotracer N-Methyl-[11c]2-(4 '-Methylaminophenyl)-6-hydroxybenzothiazole ([11C]6-Oh-bta-1)

Simplified one-pot 18F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity

Automatic synthesis of 18F-FeCH as molecular imaging agent for tumor diagnosis

Full automation of the radiosynthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) on the ALL IN ONE synthesizer

Routinely Automated Production of 3'-Deoxy-3'-[18f]fluorothymidine As a Specific Molecular Imaging Probe of Tumor Cell Proliferation

Automated “click Chemistry” Synthesis of 18F-Pen-peptide As an Apoptosis Imaging Agent

Synthesis and Fluoro-Radiolabelling of Dopamine D_2 Receptor Imaging Agent ~(18)F-FSABZM

Labeling and Imaging Study of Fatty Acid Analogue ~(18)F-FHTA on Domestic Synthesis Module

Single Step 18F-Labeling of Dimeric Cyclorgd for Functional PET Imaging of Tumors in Mice.

Simple Column Purification Technique for the Fully Automated Radiosynthesis of 2-[18F] Fluorine-N-(3-bromophenyl)-6,7-dimethoxyquinazoline-4-amine [2-18F-PD153035]